<DOC>
	<DOC>NCT02583698</DOC>
	<brief_summary>250 Acute on chronic liver failure patients with HVPG (Hepatic Venous Pressure Gradient) &gt; 12 mmHg + No/small esophageal varices who present to the Department of Hepatology at Institute of Liver and Billiary Sciences, who meet the inclusion criteria and who provide informed consent.</brief_summary>
	<brief_title>Efficacy of Nonselective Beta Blocker vs Placebo in Patients With Acute-on-chronic Liver Failure With Small/ no Esophageal Varices</brief_title>
	<detailed_description />
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Esophageal and Gastric Varices</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<criteria>1. Acute on Chronic Liver Failure as per APASL (Asian Pacific Association of Study of Liver Disease) criteria. 2. 1875 years 3. HVPG &gt; 12 + No/Small Esophageal varices 1. Bradycardia (HR &lt; 60/ min) 2. Hypotension 3. Asthma 4. LVF 5. AKI (Acute Kidney Injury) 6. Refractory ascites 7. SBP (Spontaneous Bacterial Peritonitis)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>